GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective ; volume:10 ; number:4 ; day:10 ; month:6 ; year:2019 ; pages:1205-1217 ; date:8.2019
Diabetes therapy ; 10, Heft 4 (10.6.2019), 1205-1217, 8.2019
- Creator
-
Rasalam, Roy
Barlow, John
Kennedy, Mark
Phillips, Pat
Wright, Alan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-019-0642-2
- URN
-
urn:nbn:de:101:1-2019102415022586583066
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rasalam, Roy
- Barlow, John
- Kennedy, Mark
- Phillips, Pat
- Wright, Alan
- SpringerLink (Online service)
Other Objects (12)
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off
GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers
Effects of GLP-1 receptor agonists on neurological complications of diabetes
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor
Potential implications of long-acting GLP-1 receptor agonists for critically ill
Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study